Concepedia

Beth Brooks

BB

Statistics

Publications

12

Citations

889

H-Index

11

Active since

2006

Affiliations

University of British Columbia(Current)

BC Children's Hospital

Princess Máxima Center

Erasmus MC - Sophia Children’s Hospital

Princess Margaret Cancer Centre

Beth Brooks is an author at University of British Columbia specializing in chemotherapy-related ototoxicity, medicine, and chemotherapy.

Publications per year

2006–2023

12

Publications

12

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Colin J.D. Ross, Hagit Katzov-Eckert, Marie‐Pierre Dubé et al. · Nature Genetics · 2009 · 328 citations · Full text

, , +15

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

Kusala Pussegoda, Colin J.D. Ross, Henk Visscher et al. · Clinical Pharmacology & Therapeutics · 2013 · 129 citations · Full text

, , +17

Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study

Diana J. Moke, Chunqiao Luo, Joshua Millstein et al. · The Lancet Child & Adolescent Health · 2021 · 88 citations · Full text

, , +16

Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.

David H. Henry, Beth Brooks, D. Case et al. · PubMed · 2006 · 72 citations

, , +16

Association Between <i>SLC16A5</i> Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer

Britt I. Drögemöller, Jose Gerard Monzon, Amit P. Bhavsar et al. · JAMA Oncology · 2017 · 51 citations · Full text

, , +17

1–5 of 12